• News

Deborah Doroshow, MD, on the Disappointments Uncovered About Inpatient Immunotherapy

  • Medpage Today
  • New York, NY
  • (February 16, 2023)

Deborah Doroshow, MD, PhD, discusses a study finding that cancer patients receiving care as inpatients who start on in-patient immune checkpoint inhibitors (ICI) generally do not live long enough to benefit from the drugs.

Learn more